Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-04-01
著者
-
ISHIBASHI Hiromi
Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center
-
Nomura Hideyuki
The Center For Liver Diseases Shin-kokura Hospital
-
Nomura Hideyuki
新小倉病院(共済)
-
Ishibashi Hiromi
Clinical Research Center And Department Of General Internal Medicine Nho Nagasaki Medical Center
-
MIYAGI Yugo
The Center for Liver Diseases, Shin-Kokura Hospital
-
TANIMOTO Hironori
The Center for Liver Diseases, Shin-Kokura Hospital
-
HIGASHI Masashi
Department of Internal Medicine, Higashi Hospital
-
Miyagi Yugo
The Center For Liver Diseases Shin-kokura Hospital
-
Higashi Masashi
Department Of Internal Medicine Higashi Hospital
-
Tanimoto Hironori
The Center For Liver Diseases Shin-kokura Hospital
-
ISHIBASHI Hiromi
Clinical Research Center, National Nagasaki Medical Center
-
NOMURA Hideyuki
The Center for Liver Disease, Shin-Kokura Hospital
-
TANIMOTO Hironori
The Center for Liver Disease, Shin-kokura Hospital
関連論文
- Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC) : The HLA-DRB1 polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- Body surface area is an independent factor contributing to the effects of lamivudine treatment
- Risk Factors and Prediction of Long-term Outcome in Primary Biliary Cirrhosis
- Human intrahepatic biliary epithelial cell as possible modulator of hepatic regeneration : Potential role of biliary epithelial cell for hepatic remodeling in vivo
- Increasing hepatitis C virus-associated hepatocellular carcinoma mortality and aging : Long term trends in Japan
- Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis
- 2-1). Antigen Peptide Analog : Induction of T cell Anergy in Primary Biliary Cirrhosis
- Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
- REMARKABLE EFFECTIVENESS OF ENDOSCOPIC ARGON PLASMA COAGULATION AGAINST DIFFUSE ANTRAL VASCULAR ECTASIA
- Efficacy of early retreatment with interferon β for relapse in patients with genotype Ib chronic hepatitis C
- Pilot study of prolonged interferon-α retreatment in chronic hepatitis C patients with genotype 1b
- A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development
- Triple Therapy with Ecabet Sodium, Amoxicillin and Lansoprazole for 2 Weeks as the Rescue Regimen for H. pylori Infection
- Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- Hen and egg, you mitochondria! PBC revisits mitochondria again
- Interobserver variation in assessing small bile duct lesions in PBC, CVH, and AIH
- Autoimmune Pancreatitis with Primary Sclerosing Cholangitis-like Lesion
- Liver and immune disorder
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- Primary biliary cirrhosis and autoimmune hepatitis : apotopes and epitopes
- A polymorphism in the integrin αV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients
- Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis : Japanese NHO-AIH prospective study
- Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
- Integrated fibrosis scoring by ultrasonography predicts the occurrence of hepatocellular carcinoma in patients with chronic hepatitis C virus infection
- An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
- Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders : Randomized controlled trial
- Primary biliary cirrhosis-Autoimmune hepatitis overlap syndrome : A rationale for corticosteroids use based on a nation-wide retrospective study in Japan
- Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase
- Occurrence of clinical depression during combination therapy with pegylated interferon alpha or natural human interferon beta plus ribavirin
- Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes